levodopa has been researched along with Paraplegia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bettencourt, C; Hardy, J; Houlden, H; Morris, HR; Singleton, AB | 1 |
| Anheim, M; Biskup, S; Lagha-Boukbiza, O; Mallaret, M; Namer, IJ; Rudolf, G; Tranchant, C | 1 |
| Jain, R; Mittal, M; Shukla, B | 1 |
| Guertin, PA; Rouleau, P; Ung, RV | 2 |
| Guertin, PA | 1 |
| Guertin, PA; Landry, ES | 1 |
| Antonozzi, I; Artiola, C; Carducci, C; Giovanniello, T; Leuzzi, V; Pozzessere, S; Sabato, ML; Santagata, S | 1 |
| Eriksson, J; Jankowska, E; Olausson, B | 1 |
| de Mello, MT; Poyares, DL; Tufik, S | 1 |
| Popovic, P; Popovic, V; Schaffer, R | 2 |
| Bertelsmann, FW; Smit, LM | 1 |
1 trial(s) available for levodopa and Paraplegia
| Article | Year |
|---|---|
Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions.
Topics: Adult; Benserazide; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Humans; Levodopa; Male; Movement Disorders; Nocturnal Paroxysmal Dystonia; Paraplegia; Polysomnography; Restless Legs Syndrome | 1999 |
12 other study(ies) available for levodopa and Paraplegia
| Article | Year |
|---|---|
Exome sequencing expands the mutational spectrum of SPG8 in a family with spasticity responsive to L-DOPA treatment.
Topics: Adult; Age of Onset; Amino Acid Sequence; Base Sequence; Child; DNA Mutational Analysis; Dopamine Agents; Exome; Female; Humans; Levodopa; Male; Molecular Sequence Data; Muscle Spasticity; Mutation, Missense; Paraplegia; Pedigree; Proteins; Spastic Paraplegia, Hereditary | 2013 |
SPG15: a cause of juvenile atypical levodopa responsive parkinsonism.
Topics: Adolescent; Antiparkinson Agents; Brain; Carrier Proteins; Consanguinity; Female; Gait Disorders, Neurologic; Humans; Levodopa; Magnetic Resonance Imaging; Paraplegia; Parkinson Disease | 2014 |
Delayed Diagnosis of Dopa responsive Dystonia in Two Siblings.
Topics: Child, Preschool; Delayed Diagnosis; Diagnosis, Differential; Dopamine Agents; Dystonic Disorders; Female; Humans; Levodopa; Paraplegia; Siblings | 2016 |
Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy.
Topics: Administration, Oral; Animals; Biological Clocks; Buspirone; Carbidopa; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Feasibility Studies; Gait Disorders, Neurologic; Levodopa; Male; Mice; Paraplegia; Serotonin Receptor Agonists; Spinal Cord | 2010 |
Functional and physiological effects of treadmill training induced by buspirone, carbidopa, and L-DOPA in clenbuterol-treated paraplegic mice.
Topics: Adipose Tissue; Analysis of Variance; Animals; Biomechanical Phenomena; Body Composition; Body Weight; Bone Density; Buspirone; Densitometry; Disease Models, Animal; Dopamine Agents; Exercise Test; Exercise Therapy; Histocompatibility Antigens; Levodopa; Male; Mice; Motor Activity; Muscle Fibers, Skeletal; Muscle, Skeletal; Paraplegia; Recovery of Function; Sacrococcygeal Region; Serotonin Receptor Agonists; Spinal Cord Injuries | 2012 |
Synergistic activation of the central pattern generator for locomotion by l-beta-3,4-dihydroxyphenylalanine and quipazine in adult paraplegic mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Levodopa; Locomotion; Male; Mice; Paraplegia; Quipazine; Spinal Cord Injuries | 2004 |
Differential effects of 5-HT1 and 5-HT2 receptor agonists on hindlimb movements in paraplegic mice.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Disease Models, Animal; Drug Interactions; Exercise Test; Hindlimb; Levodopa; Locomotion; Male; Mice; Movement; Paraplegia; Piperazines; Pyridines; Quipazine; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT2; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Spinal Cord Injuries | 2004 |
Tyrosine hydroxylase deficiency presenting with a biphasic clinical course.
Topics: Adolescent; DNA Mutational Analysis; Dopamine Agents; Humans; Levodopa; Male; Mutation; Paraplegia; Tyrosine 3-Monooxygenase | 2007 |
Antispastic effects of L-dopa.
Topics: Adolescent; Adrenergic Agonists; Adult; Electromyography; Female; Humans; Knee Joint; Levodopa; Male; Middle Aged; Movement; Paraplegia; Parasympatholytics; Quadriplegia; Reflex, Stretch | 1996 |
Recovery from experimental paraplegia after levodopa administration.
Topics: Animals; Decompression Sickness; Embolism, Air; Female; Levodopa; Paraplegia; Rats; Syndrome | 1976 |
Injectable agent for the treatment of air emboli-induced paraplegia in rats.
Topics: Animals; Embolism, Air; Female; Injections, Intra-Arterial; Injections, Intraperitoneal; Levodopa; Paraplegia; Rats; Time Factors | 1976 |
Progressive dystonia with marked diurnal fluctuation. Report of a case.
Topics: Carbidopa; Child; Circadian Rhythm; Conversion Disorder; Diagnosis, Differential; Drug Therapy, Combination; Dystonia; Female; Humans; Levodopa; Muscle Spasticity; Paraplegia | 1985 |